by Gunnar Eigener
Between 2013 and 2016, the Ebola virus raged through western Africa, killing over 11,000 people. A lack of preparedness, underfunding for health facilities and the stigmatization of infected individuals led to the spreading and an inability to combat the virus sooner. Nevertheless, it managed to be contained. Now, however, it risks spreading again, this time reappearing in the Democratic Republic of Congo and moving towards Uganda. Having already claimed more than 1,500 lives, the promise by world leaders that this would not happen again is ringing hollow. The actions that were supposed to speak louder than words have failed to materialise and once again, the rest of the world looks on while Africans die.
by Stu Lucy
Following the abhorrent remarks recently made by America’s comb-over-in-chief, I was impelled to pen an article outlining the plethora of innovative, iconic, and exemplary movements and people to emerge from Africa, contrasted with the shameful, embarrassing and downright inexcusable socioeconomic destitution rife across the ‘wealthiest country in the world’. However, after further consideration I imagined the brief expression of dismissive ridicule that my good friend Siraj, a native Ugandan, would have offered in hearing such an immature and ignorant statement about his fair land, and so have decided to give as little attention to it as he.
Instead my article concerns a far more serious problem endemic across the continent, one that has been allowed to become so widespread through international free trade mechanisms, that it threatens to circumvent democracy, subverting whole nations into passive submission. We shall now consider the tobacco industry’s fervent assault on Africa.Continue Reading
By Zoe Harding
Content warning – STIs
A quick reminder/PSA to the sex-having and potential-future-sex-having community: use protection, folks. The World Health Organisation released a factsheet last week describing the rapid emergence of multi-drug resistant Neisseria gonorrhoeae worldwide, with resistance to third-generation drugs reported in multiple countries including Japan and Norway.Continue Reading